Development of a novel cell line-derived xenograft model of primary herpesvirus 8-unrelated effusion large B-cell lymphoma and antitumor activity of birabresib in vitro and in vivo.
Tomohiro NishimoriTomonori HiguchiYumiko HashidaTakako UjiharaAyuko TaniguchiFumiya OgasawaraNaoya KitamuraIchiro MurakamiKensuke KojimaMasanori DaibataPublished in: Cancer medicine (2021)
These preclinical findings suggest the therapeutic potential of targeting c-MYC through BET inhibition in HHV8-unrelated effusion large B-cell lymphoma.